Addex Therapeutics Ltd. Ratios

Ratios Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 77.55%79.46%95.61%
EBT Margin -759.54%-155.00%-1,214.88%
EBIT Margin -741.04%-139.06%-681.82%
EBITDA Margin -740.43%-138.33%-634.13%
Operating Margin -741.04%-139.06%-681.82%
Net Margin -1,462.57%-654.47%1,746.04%
FCF Margin 0.74%-1,155.61%-495.94%-1,330.07%
Efficiency
Assets Average 6.93M8.65M
Equity Average 3.21M6.14M
Invested Capital 5.15M1.28M11.00M
Asset Utilization Ratio 0.260.05
Leverage & Solvency
Interest Coverage Ratio -36.06-6.98-776.78
Equity Ratio 0.590.250.91
Times Interest Earned -36.06-6.98-776.78
Valuation
Enterprise Value 27.96M-3.32M-0.53M1.93M
Market Capitalization 3.98M3.78M5.74M
Return Ratios
Return on Sales -7.03%-4.99%29.61%
Return on Capital Employed -0.67%-0.40%
Return on Assets -1.30%1.57%
Return on Equity -2.79%2.22%